Cell Proliferation News and Research

RSS

Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis

Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates and poor prognosis.

23 Sep 2025

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Osteoporosis is a degenerative disease characterized by decreased bone mass and damage to bone microarchitecture, as well as increased bone fragility.

23 Sep 2025

Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk of recurrence after surgery in patients with colon and rectal cancer with a certain type of genetic alteration in the tumor.

17 Sep 2025

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

16 Sep 2025

Study identifies C1orf122 as prognostic marker in liver cancer

Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases.

11 Sep 2025

RAB26 identified as a critical regulator of prostate cancer aggressiveness

Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has improved patient outcomes, effective therapies for advanced disease remain limited.

11 Sep 2025

Cancer cells found to use ketones as alternate fuel for growth

When it comes to their survival, cancer cells have a host of backup plans.

8 Sep 2025

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year.

5 Sep 2025

Oncolytic viruses integrated with immunotherapy for next-generation cancer treatment

The integration of oncolytic viruses (OVs) with immunotherapy is reshaping the landscape of tumor treatment, offering new hope for patients.

5 Sep 2025

Natural medicines as emerging tools to target the tumor vascular microenvironment

Recent advances in cancer treatment highlight the potential of natural medicines to target the tumor vascular microenvironment, offering a novel strategy to inhibit tumor growth and metastasis.

5 Sep 2025

Streamlining CAR T cell production through in vivo therapeutic strategies

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production.

5 Sep 2025

Targeting ADAR1 offers new hope against glioblastoma

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis.

5 Sep 2025

Breast cancer cells hijack iron-handling macrophages to promote bone metastasis and anemia

Breast cancers frequently spread to the bone, establishing tumors that are largely impervious to treatment and are associated with poor patient prognoses.

4 Sep 2025

Proteomic study reveals new drug targets in gastric signet ring cell carcinoma

Gastric signet ring cell carcinoma (GSRCC) is a distinct subtype of gastric cancer (GC) with unique epidemiological and pathogenic characteristics.

29 Aug 2025

Next-gen sequencing reveals the regulatory potential of the non-coding genome

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark achievements of the Human Genome Project (HGP), scientists have increasingly focused on deciphering the non-coding regions of the human genome, which comprise approximately 98% of the genetic material.

23 Aug 2025

Cell Proliferation News and Research

Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Study identifies C1orf122 as prognostic marker in liver cancer

RAB26 identified as a critical regulator of prostate cancer aggressiveness

Cancer cells found to use ketones as alternate fuel for growth

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Oncolytic viruses integrated with immunotherapy for next-generation cancer treatment

Natural medicines as emerging tools to target the tumor vascular microenvironment

Streamlining CAR T cell production through in vivo therapeutic strategies

Targeting ADAR1 offers new hope against glioblastoma

Breast cancer cells hijack iron-handling macrophages to promote bone metastasis and anemia

Proteomic study reveals new drug targets in gastric signet ring cell carcinoma

Next-gen sequencing reveals the regulatory potential of the non-coding genome

SOX2 drives progression and therapy resistance in advanced prostate cancer

CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management

Researchers identify molecular mechanism behind tamoxifen-related uterine cancer

ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation

Fucosylation emerges as a key player in digestive inflammatory diseases and cancers

Event Guide: 3rd Annual TRP Supply Chain & Manufacturing Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News